Huaan Fund Management Co., Ltd. increased its holding in KEYMED BIO-B (02162) by 203,500 shares at an average price of approximately HKD 72.88 per share.
The latest number of shares held after the increase is 15.096 million shares, with a latest shareholding ratio of 5.05%.
According to the latest data from the Hong Kong Stock Exchange, on July 30, Huatai Asset Management Co., Ltd. increased its holdings of KEYMED BIO-B (02162) by 203,500 shares, at a price of HKD 72.8753 per share, for a total amount of approximately HKD 14.8301 million. After the increase, the latest number of shares held is 15.096 million, representing a latest ownership ratio of 5.05%.
Related Articles
METASPACEX (01796): Delay in the publication and mailing of the annual report
Youon Technology (603776.SH) has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific investors.
Polaris Bay Group (600155.SH) plans to invest 50 million yuan to establish the Hua Chuang Innovation Intelligence Fund.
METASPACEX (01796): Delay in the publication and mailing of the annual report
Youon Technology (603776.SH) has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific investors.
Polaris Bay Group (600155.SH) plans to invest 50 million yuan to establish the Hua Chuang Innovation Intelligence Fund.
RECOMMEND
